Epsilon M&A Deal Report - Laboratoire X.O
Transaction Multiples for the Valuation of Private Companies
Private Group led by Novalpina Capital / Laboratoire X.O
No EMAT :
102982
Announced Date :
10/11/2020
Type :
LBO (Leverage Buy Out)
Deal Value :
Yes
Acquirer :
Private Group led by Novalpina Capital
Target :
Laboratoire X.O
Country :
Hauts-De-Seine
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Personal Products
Business Description :
Co-founded in 2015 by Karine Pinon and Gerard Leduc, Laboratoire X.O is a specialty pharmaceutical company that markets and sells a range of prescription and OTC drugs in France and internationally...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|||||
| Current |
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 129
- Number of EMAT Reports / sub-sector « Personal Products » = 129
| Date | Acquirer | Target | Country | Multiples | See details |
| 05/03/2019 | Funding round led by Ouest Croissance, Unexo, Arkéa Capital Investment | Nature et Stratégie | Maine-Et-Loire | * | 102609 |
| 24/10/2016 | Technature | Laboratoires Science et Mer | Finistère | * | 102591 |
Source: Epsilon Research / EMAT
